Skip to content

Cardinal Health CAH Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

McKesson logo
McKessonMCK
AbbVie logo
AbbVieABBV
Solventum logo
SolventumSOLV
Henry Schein logo
Henry ScheinHSIC
CVS Health logo
CVS HealthCVS
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$55.64B+40.8%
Enterprise value$60.62B+34.1%
P/E35.8×+10.5×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's common stock, shares issued (in shares)?
Cardinal Health (CAH) reported common stock, shares issued (in shares) of 271M in Q1 2026.
How has Cardinal Health's common stock, shares issued (in shares) changed year-over-year?
Cardinal Health's common stock, shares issued (in shares) decreased by 0.0% year-over-year, from 271M to 271M.
What is the long-term trend for Cardinal Health's common stock, shares issued (in shares)?
Over 4 years (2021 to 2025), Cardinal Health's common stock, shares issued (in shares) has grown at a -4.6% compound annual growth rate (CAGR), from 327M to 271M.